Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies

Steven Nathan, Carlo Albera, Ulrich Costabel, Ian Glaspole, Marilyn Glassberg, Lisa Lancaster, David Lederer, Carlos Pereira, Jeffrey Swigris, Andrey Pavlov, John Stauffer, Bann-Mo Day, Willis Chou, Athol Wells
  • European Respiratory Journal, September 2016, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.congress-2016.oa1765

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1183/13993003.congress-2016.oa1765

In partnership with: